Mizoribine requires individual dosing due to variation of bioavailability-Reference-Cited by-同舟云学术

Mizoribine requires individual dosing due to variation of bioavailability

Published:2012-12 Issue:6 Volume:54 Page:885-891
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatr Int

Author:

Fuke Toshiya,Abe Yoshifusa¹,Hibino Satoshi¹,Takeshi Mikawa¹,Saito Takako¹,Sakurai Shunsuke¹,Watanabe Shuichiro,Murayama Jun-Ichiro²,Itabashi Kazuo¹,Nakano Yasuko³

Affiliation:

1. Department of Pediatrics; Showa University; Japan

2. Department of Hospital Pharmaceutics; School of Pharmacy; Japan

3. Department of Pharmacogenomics; School of Pharmacy; Japan

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-200X.2012.03733.x/fullpdf

Reference32 articles.

1. Studies on bredinin. I. Isolation, characterization and biological properties;Mizuno;J. Antibiot. (Tokyo),1974

2. Mizoribine in steroid-dependent nephrotic syndrome of childhood;Hamasaki;Pediatr. Nephrol.,1997

3. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome;Yoshioka;Kidney Int.,2000

4. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome;Fujieda;Clin. Nephrol.,2008

5. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity;Ohtomo;Pediatr. Nephrol.,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities;Research and Reports in Urology;2023-07

2. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange;CEN Case Reports;2019-10-14

3. Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients;European Journal of Clinical Pharmacology;2018-11-01

4. Mizoribine in the treatment of pediatric-onset glomerular disease;World Journal of Pediatrics;2015-03-09

5. Lupus Nephritis in Asia: Clinical Features and Management;Kidney Diseases;2015